IMAGINE (Interleukin 6 Blockade Modifying Antibody-Mediated Graft INjury and eGFR Decline)
Brief description of study
Evaluate efficacy and safety of clazakizumab in preventing allograft loss in kidney transplant recipients. See section 3.1 of protocol. See section 3.2 of protocol.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Medical Research
-
Age: - 99 Years
-
Gender: All
TBD
Find a site
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting